Have £5k to invest in UK stocks? Here are my top 3 FTSE 100 shares for May

If you have spare cash available to invest in UK stocks, shares in these top FTSE 100 companies could be a strong buy in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

If you’re looking to invest £5k in the stock market crash, now could be an ideal opportunity to do so. A fresh sell-off in early May has once again sent the share prices of some top FTSE 100 stocks plunging. 

At the moment, a handful of these look like strong buys to me. Provided investors hold for the long term, I think they offer the prospect of attractive returns and sizeable dividend payouts. So, here’s my selection of top FTSE 100 shares for the month of May.

GlaxoSmithKline

Multinational pharmaceutical company GlaxoSmithKline (LSE: GSK) is on the frontline in the battle against Covid-19. The company recently announced it has joined forces with French healthcare giant Sanofi in the race to create a vaccine.

Whether successful or not, GSK looks well-set to deliver a strong performance this year. First-quarter results were impressive, with group sales rising by 19% to £9.1bn. This was driven by growth across all three of the company’s divisions, with a particularly strong showing from vaccines.

Despite this, GSK’s price-to-earnings ratio sits at a modest 13. For me, this suggests there’s value to be had as I expect high earnings and growth to continue in 2020. For that reason, I think the 4.8% yielding stock is a solid buy this May.

British American Tobacco

Making the jump from medicine to cigarettes, tobacco manufacturing company British American Tobacco (LSE: BATS) is another top FTSE 100 share in my eyes.

The so-called ‘sin stock’ boasts an eye-watering yield of around 7% and has recently pledged to stick to its dividend policy. What’s more, largely thanks to a limited impact on consumer demand, the tobacco company predicts solid earnings growth for 2020.

In line with its target, the FTSE 100 firm forecasts high single figure earnings growth in 2020. This is supplemented by an already strong start to the year, where the company saw its market share rise by 0.2%.

In my view, British American Tobacco’s pledge to stick to its dividend policy is testament to the strength of the company’s financial position. Especially when almost a third of other FTSE 100 companies are cutting or scrapping payments.

A comparatively low price-to-earnings ratio of 9 only sweetens the deal in my eyes. Moreover, steady consumer demand for its products means this company won’t be going anywhere anytime soon.

Reckitt Benckiser

Consumer goods company Reckitt Benckiser (LSE: RB) has seen its share price bounce back from a 20% plunge in the depths of the market crash to now sit 6% up on the start of the year. I think it’s clear to see why.

Last week, the company raised its full-year outlook after it reported a 12.3% rise in first-quarter sales. The impressive results were driven by an increase in demand for the firm’s hygiene products, which include Dettol, Vanish, and Nurofen.

However, with a price-to-earnings ratio of 18, shares don’t come cheap. That said, my expectations of a bumper performance in 2020, driven by unwavering consumer demand, leads me to believe the figure is justified.

All in all, I think these top FTSE 100 stocks are worthy long-term investments. In my view, investors with spare cash to spend could be well-set to profit in the long run from holding shares in each of these companies as they grow their earnings and consolidate their respective market positions.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Matthew Dumigan has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

The words "what's your plan for retirement" written on chalkboard on pavement somewhere in London
Investing Articles

Lifetime second income! 3 FTSE stocks I hope I’ll never have to sell

There are no guarantees when investing, but Harvey Jones hopes to generate a second income from these stocks for the…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

Best US stocks to consider buying in May

We asked our freelance writers to reveal the top US stocks they’d buy in May, which included a cybersecurity leader…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

Are these 2 top-performing UK growth stocks set to smash the index all over again? 

Harvey Jones is still kicking himself for failing to buy these two top FTSE 100 growth stocks last June. Now…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

1 penny stock I’d consider buying now while its share price is near 12p

This penny stock’s business looks set to explode into earnings after being a loss-maker for years. I think it’s an…

Read more »

Businesswoman analyses profitability of working company with digital virtual screen
Investing Articles

This FTSE 100 stock has what it takes to keep beating the market

Stephen Wright looks at a UK stock that's outperformed the broader market since its IPO in 2006 and looks set…

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

2 incredible passive income shares you probably haven’t heard of!

When it comes to passive income shares, there are very few companies with stronger credentials than these two. Dr James…

Read more »

Mindful young woman breathing out with closed eyes, calming down in stressful situation, working on computer in modern kitchen.
Investing Articles

Back below 70p, is the Vodafone share price set to slide?

The Vodafone share price has been a disaster over one year, five years, and a decade. But after falling below…

Read more »

Investing Articles

With a 3% yield, Warren Buffett’s investment in Coca-Cola still looks promising today

Oliver explains how Coca-Cola was one of Warren Buffett's best value investments. He thinks the shares could offer attractive dividends…

Read more »